Yazar "Nalkıran, İhsan" için PubMed İndeksli Yayınlar Koleksiyonu listeleme
-
Association of paraoxonase-1 L55M and Q192R polymorphisms with PCOS risk and potential risk factors for atherosclerosis
Nalkıran, Hatice Sevim; Şahin, Serap Baydur; Ayaz, Teslime; Nalkıran, İhsan; Güzel, Ali İrfan; Eldeş, Tuğba; Yıldız, Yasin (Future Medicine Ltd, 2019)Aim: To examine the PON1-L55M and-Q192R polymorphisms for polycystic ovary syndrome (PCOS) risk in relation with atherosclerosis risk markers. Methods: Blood samples were collected from 203 women (PCOS [n = 151], control ... -
Determination of gene expression and serum levels of MnSOD and GPX1 in colorectal cancer
Nalkıran, İhsan; Turan, Saime; Arıkan, Soykan; Kahraman, Özlem Timirci; Acar, Leyla; Yaylım, İlhan; Ergen, Arzu (Int Inst Anticancer Research, 2015)Background/Aim: Oxidative stress plays a role on the development of colorectal cancer. Manganese superoxide disnzutase (MnSOD) and glutathione peroxidase I (GPXI) are crucial in regulating oxidative balance and its ... -
Genetic variations in OLR1 gene associated with PCOS and atherosclerotic risk factors
Şahin, Serap Baydur; Nalkıran, İhsan; Ayaz, Teslime; Güzel, Ali İrfan; Eldeş, Tuğba; Calapoğlu, Tuğba; Nalkıran, Hatice Sevim (Sage Publications, 2023)Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age. The aim of this study was to investigate the association of oxidized low-density lipoprotein receptor 1 (OLR1) gene variations ... -
Prognostic importance of PD-L1 expression in bladder cancer patients
Durur, Sümeyye; Uzun, Hakkı; Bedir, Recep; Nalkıran, İhsan; Nalkıran, Hatice Sevim (Wolters Kluwer Medknow Publications, 2023)Background: PD-L1/PD-1 molecules are known as important mediators in immune-escape mechanisms of tumors. PD-L1 is highly expressed in various malignancies, including bladder cancer. However, the prognostic value of PD-L1 ... -
Targeting the anaphase-promoting complex/cyclosome (APC/C) enhanced antiproliferative and apoptotic response in bladder cancer
Nalkıran, Hatice Sevim; Yıldız, Dilara Akcora; Saydam, Faruk; Güzel, Ali İrfan; Nalkıran, İhsan (Elsevier, 2023)Improving the chemotherapy sensitivity of bladder cancer is a current clinical challenge. It is critical to seek out effective combination therapies that include low doses of cisplatin due to its dose-limiting toxicity. ...